Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Endocrine 1CNS 1

Conditions

Sarcoma 111Osteosarcoma 41Sarcoma, Ewing 30Rhabdomyosarcoma 28Melanoma 28Neuroblastoma 21Glioblastoma 18Bone Neoplasms 18Rhabdoid Tumor 17Lymphoma, Non-Hodgkin 17Gliosarcoma 16Neoplasms 15Neoplasm Metastasis 15Liposarcoma 15Breast Neoplasms 15Wilms Tumor 14Ovarian Neoplasms 14Glioma 14Medulloblastoma 13Leiomyosarcoma 13Gastrointestinal Stromal Tumors 13Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Hepatoblastoma 12Colorectal Neoplasms 12Sarcoma, Synovial 11Ependymoma 11Chordoma 11Carcinoma, Renal Cell 11Neurofibrosarcoma 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Vascular Neoplasms × Sarcoma × Clear all
NCT06453642 2026-03-30

GPX

Fluidx Medical Technology, Inc.

Phase NA Active not recruiting
114 enrolled
GenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Angiomyolipoma, Vascular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡